SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006868
Filing Date
2019-05-13
Accepted
2019-05-13 11:34:31
Documents
33
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 257544
2 form10-q_001.jpg GRAPHIC 4447
3 ex31-1.htm EX-31.1 15421
4 ex31-2.htm EX-31.2 15459
5 ex32-1.htm EX-32.1 7133
  Complete submission text file 0001493152-19-006868.txt   936278

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vapa-20190331.xml EX-101.INS 53948
7 XBRL SCHEMA FILE vapa-20190331.xsd EX-101.SCH 13092
8 XBRL CALCULATION FILE vapa-20190331_cal.xml EX-101.CAL 21155
9 XBRL DEFINITION FILE vapa-20190331_def.xml EX-101.DEF 30226
10 XBRL LABEL FILE vapa-20190331_lab.xml EX-101.LAB 93630
11 XBRL PRESENTATION FILE vapa-20190331_pre.xml EX-101.PRE 70123
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

IRS No.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 19817402
SIC: 2834 Pharmaceutical Preparations